Preliminary Safety and Biomarker Results of the NLRP3 Inflammasome Inhibitor DFV890 in Adult Patients with Myeloid Diseases: A Phase 1b Study

Guillermo Garcia‐Manero, Harinder Gill, Peter L. Greenberg et al.|Blood|2024

Cited by 9